Garysc, I would (honestly) like to see that, but quite frankly man, it's not going to happen ( yet ! ).
I would like to see it happen though because I think there are a couple of somewhat disingenuous posters on this thread, uber selfish, who ramp and down-ramp. Unfortunately, they trap young investors, and take their money, which I don't like to see, here or anywhere. I'm too old for that crap, but old enough to recognise it. And anyway, I'm an altruist.
Most people on HC are great, but a few are greedy and duplicitous.
Look at the trading over the past month. TND won't delay for long. They might wait and see how the new contract news goes down, and if it is brilliantly received (as it should be), then they might just make it to 10c. That would be fair.
It's a game. And we can only hypothesize.
They may want to call a trading halt while the stock is trading above 5 cents though (who knows), or if they are smart (and they are), at the high point of the rise after announcing new contracts, hopefully above 10 cents.
Anyway, I'm not sure why it has to be 5c or 10c, what's wrong with 6c, or 7c, or 8c - basically whatever the value is at the time.
Regardless, the future for facial recognition software is enormous, and I've been in the I.T. consultancy game for 25 years, and worked on 3 continents. The algorithms can be applied to a hundred other sciences, including agriculture, which should be interesting, given the world's booming population. Just read up on the science and extrapolate. But I've said before, sometimes it's not the best technology that wins (look at Microsoft), there are many factors to winning in business (which is a conversation for another time).
It's all good here at AnyVision. Just wait.
Gw
- Forums
- ASX - By Stock
- MYL
- Ann: TND successful completion of Anyvision due diligence
Ann: TND successful completion of Anyvision due diligence, page-43
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online